# Nephrology Dialysis Transplantation

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/nephrology-dialysis-transplantation/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 3,431 |
| Citations | 723,735 |
| h-index | 234 |
| Homepage | http://ndt.oxfordjournals.org/ |
| Open Access | false |
| ISSN-L | 0931-0509 |
| ISSNs | 0931-0509,1460-2385 |
| OpenAlex ID | https://openalex.org/S186113128 |
| Publisher | Oxford University Press |
| Works | 42,110 |

## Journal papers

Showing 12 of 258.

- [Oxidative stress in end-stage renal disease: an emerging threat to patient outcome](https://scholariq.org/papers/oxidative-stress-in-end-stage-renal-disease-an-emerging-threat-to-patient/)
- [When do we need competing risks methods for survival analysis in nephrology?](https://scholariq.org/papers/when-do-we-need-competing-risks-methods-for-survival-analysis-in-nephrology/)
- [The mortality risk of overhydration in haemodialysis patients](https://scholariq.org/papers/the-mortality-risk-of-overhydration-in-haemodialysis-patients/)
- [Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure](https://scholariq.org/papers/morphology-of-coronary-atherosclerotic-lesions-in-patients-with-end-stage-renal/)
- [A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases](https://scholariq.org/papers/a-single-number-for-advocacy-and-communication-worldwide-more-than-850-million/)
- [Chronic kidney disease as cause of cardiovascular morbidity and mortality](https://scholariq.org/papers/chronic-kidney-disease-as-cause-of-cardiovascular-morbidity-and-mortality/)
- [Clinical practice guideline on diagnosis and treatment of hyponatraemia](https://scholariq.org/papers/clinical-practice-guideline-on-diagnosis-and-treatment-of-hyponatraemia-2/)
- [An estimated glomerular filtration rate equation for the full age spectrum](https://scholariq.org/papers/an-estimated-glomerular-filtration-rate-equation-for-the-full-age-spectrum/)
- [Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population](https://scholariq.org/papers/serum-ipth-calcium-and-phosphate-and-the-risk-of-mortality-in-a-european/)
- [Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement](https://scholariq.org/papers/kidney-disease-improving-global-outcomes-guidelines-on-anaemia-management-in/)
- [Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)](https://scholariq.org/papers/anaemia-in-haemodialysis-patients-of-five-european-countries-association-with/)
- [Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease](https://scholariq.org/papers/free-p-cresylsulphate-is-a-predictor-of-mortality-in-patients-at-different/)

## Journal top topics

Showing 8 of 25.

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)
- [Renal and Vascular Pathologies](https://scholariq.org/topics/renal-and-vascular-pathologies/)
- [Organ Donation and Transplantation](https://scholariq.org/topics/organ-donation-and-transplantation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.